Evidence map›Paper›PMID 19118716›Full record

ArticleJournal of the American College of Cardiology2009

Mobilization of bone marrow-derived Oct-4+ SSEA-4+ very small embryonic-like stem cells in patients with acute myocardial infarction.

Wojciech Wojakowski, Michał Tendera, Magda Kucia, Ewa Zuba-Surma, Edyta Paczkowska, Joanna Ciosek, Maciej Hałasa, Marek Król, Maciej Kazmierski, Paweł Buszman and 4 more

Registry-linked trialOpen access · greenAbstract readComparative Study
In one paragraph

Article in Journal of the American College of Cardiology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01633359 (The Randomly Controlled Clinical Trial of the Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients), which is not on this map. Cited by 103 papers.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed
11.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01633359 phase4unknown statusstarted 2012, after this paper: background citation

The Randomly Controlled Clinical Trial of the Association Between Very Small Embryonic-like Stem Cells and the Prognosis of Coronary Artery Disease Patients

Ran2012Enrolled300Registered outcomes2Posted comparisons0ConditionsCoronary Artery DiseaseArmsIntensive statin, Routine statin
Open the trial in the graph
3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 237 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Stem cells mobilization by cardiopulmonary bypass after coronary artery bypass grafting.Postepy w kardiologii interwencyjnej = Advances in interventional cardiology · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Observational
  18. Review
  19. Article
  20. Review

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Wojciech WojakowskiThird Division of Cardiology, Medical University of Silesia, Katowice, Poland.
Michał Tendera
Magda Kucia
Ewa Zuba-Surma
Edyta Paczkowska
Joanna Ciosek
Maciej Hałasa
Marek Król
Maciej Kazmierski
Paweł Buszman
Andrzej Ochała
Janina Ratajczak
Bogusław Machaliński
Mariusz Z Ratajczak
Medical University of Silesia · PLPomeranian Medical University · PLJames Graham Brown Foundation · USAmerican Heart of Poland · PL

Funding

The CXCR4-SDF-1 Axis in Metastatic RhabdomyosarcomaR01CA106281 · NCI · UNIVERSITY OF LOUISVILLE · PI RATAJCZAK, MARIUSZ Z · 2005 to 2009
$1.3M
NCI NIH HHS R01 CA106281NCI NIH HHS R01 CA106281-01
6 · The paper itself

Abstract

objectivesThis study sought to assess of the mobilization of nonhematopoietic very small embryonic-like stem cells (VSELs) in acute myocardial infarction (MI).

backgroundAcute MI induces mobilization of bone marrow stem cells. Recently, a rare population of VSELs, expressing markers of embryonic pluripotent stem cells (PSCs), was identified in adult murine bone marrow and human umbilical cord blood.

methodsThirty-one patients with acute MI and 30 healthy subjects were enrolled. Blood was sampled on admission, after 24 h, and 5 days later. Erythrocytes were lysed and lin(-)CD45(-) VSELs were isolated using a live cell sorting system (FACSAria, Beckton Dickinson, San Jose, California).

resultsIn healthy subjects the median number of circulating VSELs was very low (median 0.8 [range 0 to 1.3]) cells/microl. In acute MI, VSELs were mobilized early (median 2.7 [range 0.2 to 3.9] cells/microl; p < 0.001) and remained elevated after 24 h and 5 days (median 4.7 [range 0.2 to 6.4] cells/microl; p < 0.003, and median 2.6 [range 0.3 to 3.6] cells/microl; p < 0.03, respectively). The mobilization of VSEL was significantly reduced in patients older than 50 years and with diabetes in comparison with younger and nondiabetic patients. Circulating VSELs were small (7 to 8 microm) and enriched in the messenger ribonucleic acid of PSC markers (Oct-4, Nanog), cardiac lineage (GATA-4, Nkx2.5/Csx, MEF2C), and endothelial (VE-cadherin) markers. The presence of PSC markers (Oct-4, SSEA-4) and the chemokine receptor CXCR4 in circulating VSELs was confirmed at the protein level by immunofluorescent staining and ImageStream system (Amnis Corporation, Seattle, Washington) analysis.

conclusionsAcute MI induced mobilization of VSELs expressing pluripotent markers, early cardiac and endothelial markers, and chemokine receptor CXCR4.

Indexed as

Cell LineageHematopoietic Stem Cell MobilizationAdultAgedBiomarkersBone Marrow CellsCase-Control StudiesCell SeparationEmbryonic Stem CellsFemaleFetal BloodGene ExpressionHumansMaleMiddle AgedMyocardial InfarctionBiomarkersOctamer Transcription Factor-3stage-specific embryonic antigen-4Stage-Specific Embryonic Antigens

Identifiers

PMID19118716
PMCPMC5536894
OpenAlexW2029131065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.